The Division of Technology Development and Industry Sponsored Research (Technology Development) initiates, negotiates and manages research relationships with industry and the transfer of research results to commercial application. The objective is to make the College's research available for public use and benefit and to generate new revenue streams to support research. A major effort is to find companies with the capability, interest and resources to develop embryonic technologies into useful products.
Technology Development, directed by Charles Hathaway, Ph.D. (914-594-2600) negotiates licenses, confidentiality agreements, materials transfer agreements and non-clinical research agreements with commercial sponsors. All research contracts with commercial sponsors must conform with College policies. Contracts are reviewed to protect the investigator's freedom to publish, the College's right to patentable or copyrightable materials, and use of the College's name. Appropriate costs, including indirect costs at 30%, must be budgeted. Copies of the "NYMC Agreement Guidelines for Industry Sponsored Research" are available to investigators and to their potential commercial sponsors.
All inventions developed by employees of the College through the use of the College's resources must be disclosed whether or not the project is sponsored by an external sponsor. Inventions include such things as new or improved devices, chemical compounds, drugs, genetically-engineered biological organisms, data sets, software, or unique and innovative uses of existing inventions. The Intellectual Property kit contains a disclosure statement form, the College's intellectual property policies, advice on preparing and maintaining laboratory notebooks, and sample confidentiality and materials transfer agreements.
Technology Development has an active program of obtaining patent protection and commercializing opportunities for its investigators' viable product innovations. In return, investigators along with their departments and the College share in royalty income from inventions or patents as specified in the Intellectual Property Policy. Technology Development assists inventors in determining when articles about potentially patentable discoveries can be published without causing the loss of patent rights. Provisional patent applications which protect an invention for one year may be filed to provide a preterm period in which to evaluate the commercial potential of an invention and find a license.
Faculty and commercial sponsors may contact Charles Hathaway, Ph.D. for more information on technology transfer and industry sponsored research or a listing of available New York Medical College's Technologies Available for License.